提示:《Chinese Journal of Cancer》投稿需先进行学术不端检测,查重需低于10%。需要按照投稿格式进行撰写,论文可以先进行排版,整理好再进行递交。
im
portant notice
We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1st March 2018.
Please click the l
inks below for more information of Cancer Communications
http://www.cancercommin.com
https://cancercommun.biomedcentral.com
a
bout the cover
pISSN: 1000-467X
eISSN: 1944-446X
CN: 44-1195/R
View o
nlineFirst Articles
New articles accepted recently
View Current Issue
Volume 36 Issue 12
Browse Past Issues
From January 2002
In this issue
Awakening immunity against cancer: a 2017 primer for clinicians
Famitinib versus placebo in the treatment of refractory me
tastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
Systematic analyses of glutamine and glutamate me
tabolisms across different cancer types
[查看详情]